Related Experiment Videos
[General anesthesia in two patients with mitochondrial myopathy]
A Klockgether-Radke1, T Henze, U Braun
1Zentrum Anästhesiologie, Rettungs- und Intensivmedizin, Georg-August-Universität Göttingen.
Der Anaesthesist
|February 1, 1993
Summary
General anesthesia using propofol with alfentanil or fentanyl is safe for patients with mitochondrial myopathy (Kearns-Sayre syndrome). This anesthetic approach allows for rapid recovery and extubation, managing potential complications effectively.
Area of Science:
- Anesthesiology
- Neurology
- Genetics
Background:
- Mitochondrial myopathies, such as Kearns-Sayre syndrome, present unique anesthetic challenges.
- These challenges include potential myocardial conduction disturbances, postoperative hypotonia, and increased susceptibility to malignant hyperthermia.
Observation:
- Two patients with mitochondrial myopathy underwent general anesthesia.
- The first patient received propofol-alfentanil anesthesia, while the second received propofol-fentanyl anesthesia.
- Both cases involved vecuronium for muscle relaxation and experienced transient bradycardia, successfully treated with atropine.
Findings:
- Both patients regained consciousness rapidly after propofol infusion cessation.
- Prompt spontaneous ventilation returned, enabling swift extubation.
- Neuromuscular blockade reversal with neostigmine was effective in the second patient.
Implications:
- The described anesthetic management, utilizing propofol-based regimens, appears effective for patients with mitochondrial myopathies.
- This approach can successfully navigate potential anesthetic risks associated with these conditions.
- It offers a viable strategy for safe surgical procedures in patients with mitochondrial myopathies.